Xinhua News Agency, Tianjin, June 30: China's marine drugs will be accumulated by technology into the product development stage. In the next 10 years, a group of marine drugs and health products will be formed, which will play an important role in anti-AIDS, anti-tumor, and health care.
A report recently released by the China Biotechnology Development Center of the Ministry of Science and Technology at the "2009 International Conference on Bioeconomy" held in Tianjin indicated that under the impetus of the development of marine science and technology, China's marine biology industry has shown industrialization, scale, and efficiency. The characteristics of development. The development of marine organisms as health care, drugs and functional materials has formed an industry, and a number of biopharmaceutical companies have rapidly emerged.
In the next 10 years, China will focus on deep-sea fishing and ocean-going fishing, break through the bottleneck of fishing and aquaculture, accelerate the development of the marine industry, and greatly increase marine production capacity. At the same time, we will clone a group of important functional genes from marine organisms. And it has formed a batch of marine drugs and health products that play an important role in anti-AIDS, anti-tumor and other aspects.
At present, there are more than 800,000 people living with HIV in China. The deaths caused by malignant tumors and cardiovascular and cerebrovascular diseases account for 60% to 70% of total deaths in the population, total deaths from working age, and especially the total number of deaths from the best workforce loss. Therefore, the development of marine drugs will play a major role in the treatment and intervention of these major diseases.
The report also pointed out that in the future, China will also make major breakthroughs in the research and application of marine biological materials and marine biological enzymes, and form a new batch of industries. (Reporter Zhou Runjian, Zhu Shaobin)